Subscribe to Specialty Providers

Specialty Providers

CORE is key to BioScrip reversal

 - 
03/10/2017

DENVER – BioScrip has pushed closer to its goal of having its core home infusion business make up 85% of its overall revenue, said company executives on a recent earnings call.

Infusion providers take Medicare patients ‘case by case’

 - 
02/24/2017

YARMOUTH, Maine – One of the leading providers of home infusion therapy has stopped taking new Medicare patients and others are likely to follow suit if a “payment gap” is not closed.

Medtrade Spring preview: Keep reserves

‘While we don’t know what crisis is around the corner, we understand that a crisis will occur,’ says speaker Steve Burman
 - 
02/10/2017

LAS VEGAS – Although considerable challenges exist within the HME industry, astute companies can still find prosperity in the market, provider Steve Burman says.

OIG updates Medicare market shares for diabetes test strips

 - 
02/07/2017

WASHINGTON – Suppliers in Medicare’s national mail-order program provided 18 types of diabetes test strips to beneficiaries from July through September 2016, according to a new report from the Office of Inspector General.

Program has prescription for success

 - 
01/27/2017

Community pharmacies are doing more these days than just filling prescriptions. They’re  offering immunizations, lab testing, educational classes and other services that reflect the growing role of pharmacies as part of the healthcare team. 

Reporter’s notebook: Love them or hate them, bid contracts at heart of most-read stories

 - 
01/27/2017

From diabetes supplies to wound care to vents, this year’s list of most read specialty provider stories covered a lot of different markets, but they all had one thing in common: CMS.

Home infusion stakeholders: Fix the gap

 - 
01/27/2017

WASHINGTON – Home infusion stakeholders want a fast fix for a payment gap that will limit patient access to therapy.

CMS approves CGMs—what now?

 - 
01/27/2017

WASHINGTON – CMS’s recent decision to classify certain continuous glucose monitoring systems as DME is a positive step, but there are a few dominoes that need to fall before they are paid for, say stakeholders.

Home infusion stakeholders press for fix

 - 
01/26/2017

WASHINGTON – More than 170 home infusion stakeholders signed a letter asking lawmakers to fix the “damaging” reimbursement gap created by the 21st Century Cures Act.

Moneyline: PharMerica, FOSRx make buys

 - 
01/25/2017

LOUISVILLE, Ky. – Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.

Pages